Low ACCI

 (n 108)

High ACCI

(n 65)

P value

Odds Ratio (95% CI)

Sex

0.071

1.788 (0.950, 3.365)

Male

73 (67.6%)

35 (53.8%)

Female

35 (32.4%)

30 (46.2%)

Age

< 0.001

10.038 (4.749, 21.218)

≤ 70 years

75 (69.4%)

12 (18.5%)

≥ 71 years

33 (30.6%)

53 (81.5%)

SIMD (decile)

1 - 3

45 (41.7%)

28 (43.1%)

0.856

0.944 (0.507, 1.759)

4 - 6

31 (28.7%)

26 (40.0%)

0.126

0.604 (0.316, 1.155)

≥ 7

31 (28.7%)

11 (16.9%)

0.080

1.976 (0.914, 4.272)

Address not recognised

1 (0.9%)

0 (0.0%)

0.437

Inf (Nan, Inf)

Lymphopenia (x 10^*g/L)

61 (56.5%)

40 (61.5%)

0.513

0.811 (0.433, 1.520)

Neutrophils (x 10^*g/L)

Decreased ( < 2.0)

2 (1.8%)

4 (6.1%)

0.134

0.288 (0.051, 1.617)

Normal (2.0 - 7.5)

73 (67.6%)

38 (58.5%)

0.225

1.482 (0.784, 2.802)

Increased ( > 7.5)

33 (30.6%)

23 (35.4%)

0.511

0.803 (0.418, 1.543)

Platelets (x 10^*g/L)

Decreased (< 140)

10 (9.3%)

15 (23.1%)

0.012

0.340 (0.143, 0.812)

Normal (140 - 450)

94 (87.0%)

49 (75.4%)

0.050

2.192 (0.989, 4.860)

Increased (> 450)

4 (3.7%)

1 (1.5%)

0.410

2.462 (0.269, 22.513)

Egfr ≥ 59 (ml/mn/1.73m2)

85 (78.7%)

29 (44.6%)

< 0.001

4.588 (2.343, 8.982)

CRP  (mg/L)

0.002

0.335 (0.168, 0.668)

≤ 100

57 (52.8%)

50 (76.9%)

≥ 101

51 (47.2%)

15 (23.1%)

First RT-PCR swab positive

91 (84.3%)

61 (93.8%)

0.061

0.351 (0.113, 1.094)

Admission category

Group 1

94 (87.0%)

37 (56.9%)

< 0.001

5.081 (2.410, 10.712)

Group 2

6 (5.6%)

16 (24.6%)

< 0.001

0.180 (0.066, 0.489)

Group 3

8 (7.4%)

12 (18.5%)

0.028

0.353 (0.136, 0.918)

CXR (BSTI Classification)

CVCX0

10 (9.2%)

18 (27.7%)

0.001

0.266 (0.114, 0.622)

CVCX1

53 (49.1%)

14 (21.5%)

< 0.001

4.256 (2.048, 8.844)

CVCX2

40 (37.0%)

25 (38.5%)

0.851

0.941 (0.499, 1.775)

CVCX3

3 (2.8%)

7 (10.8%)

0.029

0.237 (0.059, 0.950)

Not done

2 (1.9%)

1 (1.5%)

0.878

1.208 (0.107, 13.586)